Last update 11 Jul 2025

BJG-02-095

Overview

Basic Info

Drug Type
Proteolysis-targeting chimeras (PROTAC)
Synonyms
BJG-02-095
Target
alpha-tubulin x β-tubulin
Action
degraders, inhibitors
Mechanism
alpha-tubulin degraders(Tubulin alpha degraders), alpha-tubulin inhibitors(Tubulin alpha inhibitors), β-tubulin degraders(tubulin beta class I degraders)
Therapeutic Areas
Neoplasms
Active Indication-
Inactive Indication
Neoplasms
Originator Organization
Harvard Medical SchoolHarvard Medical SchoolUniversity of Wisconsin MadisonUniversity of Wisconsin Madison
Active Organization-
Inactive Organization
Harvard Medical SchoolHarvard Medical SchoolDana-Farber Cancer Institute, Inc.Dana-Farber Cancer Institute, Inc.
License Organization-
Drug Highest PhasePendingPreclinical
First Approval Date-
Regulation-

Structure/Sequence

Molecular FormulaC64H98N8O12
InChIKeyOXTCTKVCXZYWPJ-BYOFMMMDSA-N
CAS Registry-

Related

100 Clinical Results associated with BJG-02-095
Login to view more data
100 Translational Medicine associated with BJG-02-095
Login to view more data
100 Patents (Medical) associated with BJG-02-095
Login to view more data
100 Deals associated with BJG-02-095
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
NeoplasmsPreclinical
United States
Dana-Farber Cancer Institute, Inc.Dana-Farber Cancer Institute, Inc.
27 Apr 2020
NeoplasmsPreclinical
United States
Harvard Medical SchoolHarvard Medical School
27 Apr 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free